Connection
Deanne King to Doxorubicin
This is a "connection" page, showing publications Deanne King has written about Doxorubicin.
|
|
Connection Strength |
|
|
|
|
|
0.044 |
|
|
|
-
Voelkel-Johnson C, King DL, Norris JS. Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL. Cancer Gene Ther. 2002 Feb; 9(2):164-72.
Score: 0.044